NO315331B1 - Fremgangsmate for fremstilling av et konsentrat av anti-D- immunglobulin G samt farmasoytisk preparat inneholdende dette - Google Patents

Fremgangsmate for fremstilling av et konsentrat av anti-D- immunglobulin G samt farmasoytisk preparat inneholdende dette Download PDF

Info

Publication number
NO315331B1
NO315331B1 NO19945032A NO945032A NO315331B1 NO 315331 B1 NO315331 B1 NO 315331B1 NO 19945032 A NO19945032 A NO 19945032A NO 945032 A NO945032 A NO 945032A NO 315331 B1 NO315331 B1 NO 315331B1
Authority
NO
Norway
Prior art keywords
igg
plasma
adsorbent
ion exchange
rhesus
Prior art date
Application number
NO19945032A
Other languages
English (en)
Norwegian (no)
Other versions
NO945032L (no
NO945032D0 (no
Inventor
Gerhard Hodler
Peter Lerch
Martin Stucki
Original Assignee
Zlb Bioplasma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8215103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO315331(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zlb Bioplasma Ag filed Critical Zlb Bioplasma Ag
Publication of NO945032D0 publication Critical patent/NO945032D0/no
Publication of NO945032L publication Critical patent/NO945032L/no
Publication of NO315331B1 publication Critical patent/NO315331B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
NO19945032A 1993-12-27 1994-12-23 Fremgangsmate for fremstilling av et konsentrat av anti-D- immunglobulin G samt farmasoytisk preparat inneholdende dette NO315331B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP93810912A EP0659767B2 (fr) 1993-12-27 1993-12-27 Procédé de préparation d'un concentré d'immunoglobuline G anti-D et compositions pharmaceutiques qui le contiennent

Publications (3)

Publication Number Publication Date
NO945032D0 NO945032D0 (no) 1994-12-23
NO945032L NO945032L (no) 1995-06-28
NO315331B1 true NO315331B1 (no) 2003-08-18

Family

ID=8215103

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19945032A NO315331B1 (no) 1993-12-27 1994-12-23 Fremgangsmate for fremstilling av et konsentrat av anti-D- immunglobulin G samt farmasoytisk preparat inneholdende dette

Country Status (20)

Country Link
US (1) US5593675A (fr)
EP (1) EP0659767B2 (fr)
JP (1) JP2926463B2 (fr)
KR (1) KR100368563B1 (fr)
AT (1) ATE175979T1 (fr)
AU (1) AU682243B2 (fr)
CA (1) CA2138921C (fr)
CZ (1) CZ286271B6 (fr)
DE (1) DE59309332D1 (fr)
DK (1) DK0659767T4 (fr)
ES (1) ES2129076T5 (fr)
FI (1) FI112168B (fr)
GR (1) GR3029817T3 (fr)
HU (1) HU216864B (fr)
NO (1) NO315331B1 (fr)
NZ (1) NZ278057A (fr)
PL (1) PL180358B1 (fr)
SI (1) SI9420008B (fr)
TW (1) TW311884B (fr)
WO (1) WO1995018155A1 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE370961T1 (de) * 1998-05-06 2007-09-15 Genentech Inc Reinigung von antikörpern durch ionenaustauschchromatographie
DK2270044T3 (en) * 1998-06-09 2015-01-26 Csl Behring Ag Liquid immunoglobulin G (IgG) product
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren
US6475749B1 (en) * 1999-08-11 2002-11-05 The Regents Of The University Of California Rh hybrid antibody
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
EP1532983A1 (fr) 2003-11-18 2005-05-25 ZLB Bioplasma AG Preparation d'immunoglobulines à stabilité élevée
CA2458750C (fr) 2004-02-23 2012-02-07 Bayer Inc. Methode de production d'un produit a base d'isoolefine-diolefine et appareil connexe
US20060263357A1 (en) * 2005-05-05 2006-11-23 Tedder Thomas F Anti-CD19 antibody therapy for autoimmune disease
TWI391399B (zh) 2005-05-25 2013-04-01 赫孚孟拉羅股份公司 測定溶離多肽之鹽濃度之方法
KR20090058532A (ko) * 2006-08-28 2009-06-09 아레스 트레이딩 에스.에이. Ｆｃ­융합 단백질을 정제하는 방법
JP2010501623A (ja) * 2006-08-28 2010-01-21 アレス トレーディング ソシエテ アノニム Ｆｃ含有タンパク質の精製法
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
DK2531218T3 (en) 2010-02-04 2019-04-01 Csl Behring Ag immunoglobulin
EP2361636A1 (fr) 2010-02-26 2011-08-31 CSL Behring AG Préparation d'immunoglobuline et système de stockage pour préparation d'immunoglobuline
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
PL2616090T3 (pl) * 2010-09-17 2023-12-18 Takeda Pharmaceutical Company Limited Stabilizowanie immunoglobulin poprzez wodną formulację z histydyną o ph od słabo kwaśnego do obojętnego
CA2846599A1 (fr) * 2011-08-26 2013-03-07 Baxter International Inc. Procede pour la reduction du potentiel thromboembolique d'une composition d'immunoglobuline derivee du plasma
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
KR101917196B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
EP3118210B1 (fr) * 2014-03-11 2019-11-13 Green Cross Holdings Corporation Procédé de purification d'immunoglobuline
CN121371151A (zh) 2014-12-03 2026-01-23 瑞士杰特贝林生物制品有限公司 具有增加的稳定性的包含免疫球蛋白的药物产品
US12247065B2 (en) * 2018-06-22 2025-03-11 Genmab A/S Method for producing a controlled mixture of two or more different antibodies
CN114456271A (zh) * 2020-11-10 2022-05-10 新疆德源生物工程有限公司 一种Rho(D)人免球蛋白的生产工艺
EP4349859A1 (fr) * 2023-01-27 2024-04-10 CSL Behring AG Méthode de purification de l'immunoglobuline g anti-d à partir du plasma
WO2024156861A1 (fr) * 2023-01-27 2024-08-02 Csl Behring Ag Procédé de réduction de l'activité protéase dans une solution comprenant une immunoglobuline g anti-d

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
EP0085747B2 (fr) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Immunoglobuline humaine pour administration intraveineuse et son procédé de préparation
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins

Also Published As

Publication number Publication date
SI9420008B (sl) 1998-06-30
FI946103L (fi) 1995-06-28
DK0659767T3 (da) 1999-09-13
HU9502514D0 (en) 1995-11-28
SI9420008A (en) 1996-02-29
CA2138921C (fr) 2004-11-02
AU682243B2 (en) 1997-09-25
EP0659767A1 (fr) 1995-06-28
ATE175979T1 (de) 1999-02-15
HU216864B (hu) 1999-09-28
CZ249295A3 (en) 1996-01-17
DE59309332D1 (de) 1999-03-04
NO945032L (no) 1995-06-28
WO1995018155A1 (fr) 1995-07-06
CZ286271B6 (cs) 2000-03-15
PL180358B1 (pl) 2001-01-31
NO945032D0 (no) 1994-12-23
KR960701098A (ko) 1996-02-24
FI112168B (fi) 2003-11-14
EP0659767B2 (fr) 2002-11-06
FI946103A0 (fi) 1994-12-27
AU1414395A (en) 1995-07-17
KR100368563B1 (ko) 2003-04-03
NZ278057A (en) 1997-03-24
JP2926463B2 (ja) 1999-07-28
CA2138921A1 (fr) 1995-06-28
DK0659767T4 (da) 2003-02-10
HUT73376A (en) 1996-07-29
PL310435A1 (en) 1995-12-11
ES2129076T5 (es) 2003-05-16
JPH07206708A (ja) 1995-08-08
TW311884B (fr) 1997-08-01
GR3029817T3 (en) 1999-06-30
EP0659767B1 (fr) 1999-01-20
US5593675A (en) 1997-01-14
ES2129076T3 (es) 1999-06-01

Similar Documents

Publication Publication Date Title
US5593675A (en) Method of producing an anti-D immunoglobulin concentrate and a pharmaceutical preparation
US5886154A (en) Chromatographic method for high yield purification and viral inactivation of antibodies
US20070244305A1 (en) Process for The Manufacture of Virus Safe Immunoglobulin
US6955917B2 (en) Chromatographic method for high yield purification and viral inactivation of antibodies
EP3305800B1 (fr) Procédé de préparation d'agent d'immunoglobuline humaine contre l'hépatite b dérivé de plasma
DK157367B (da) Fremgangsmaade til fremstilling af intravenoest administrerbart humant immunoglobulin
Hässig Intravenous immunoglobulins: pharmacological aspects and therapeutic use
Wordell Use of intravenous immune globulin therapy: an overview
HK1009277B (en) Process to prepare an anti-d immunoglobulin g concentrate and pharmaceutical compositions comprising it
HK1009277A1 (en) Process to prepare an anti-d immunoglobulin g concentrate and pharmaceutical compositions comprising it
US20240301036A1 (en) Treatment of intestinal lumen immunoglobulin deficiency with semisynthetic polyclonal human secretory immunoglobin a
Burnouf Preprint of a manuscript published in Toxicon
Yap Humoral Functions of Immunoglobulin: Relationship to Purification Technology of Intravenous Immunoglobulin
dans la Region Ulllted States Patent [19][11] Patent Number: 6,069,236

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees